Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$5,192,438
+$82,521 QoQ
Shares Held
14,339
-1.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#819
of 3,140 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meridian Wealth Management, LLC holds $80,207,351 across 13 Drug Manufacturers - General names. AMGN ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
77,358 | $19,466,367 | |
| 2 | LLY |
ELI LILLY & Co
|
15,030 | $18,027,434 | |
| 3 | JNJ |
Johnson & Johnson
|
53,587 | $13,609,490 | |
| 4 | MRK |
Merck & Co., Inc.
|
79,604 | $10,229,114 | |
| 5 | AMGN |
Amgen Inc
This page
|
14,339 | $5,192,438 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
40,890 | $5,166,042 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
52,891 | $3,047,579 | |
| 8 | PFE |
Pfizer Inc
|
103,774 | $2,498,877 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,192,438 | 14,339 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $5,109,917 | 14,523 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $4,740,758 | 14,484 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $4,031,227 | 14,285 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,104,666 | 14,701 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,582,588 | 14,709 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,047,478 | 15,529 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $5,105,739 | 15,846 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $4,416,911 | 15,535 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $4,342,765 | 15,078 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,406,477 | 8,954 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $1,097,000 | 4,941 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,147,829 | 4,748 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $911,886 | 3,472 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $481,003 | 2,134 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $560,076 | 2,302 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $283,171 | 1,171 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $248,591 | 1,105 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $295,158 | 1,388 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $332,475 | 1,364 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $219,450 | 882 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $335,913 | 1,461 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $216,290 | 851 | Shares | Sole | 2020-10-09 | |
| 2020-03-31 | $202,730 | 1,000 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||